282 related articles for article (PubMed ID: 37946175)
1. A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer.
Kalantari L; Ghotbabadi ZR; Gholipour A; Ehymayed HM; Najafiyan B; Amirlou P; Yasamineh S; Gholizadeh O; Emtiazi N
Cell Commun Signal; 2023 Nov; 21(1):318. PubMed ID: 37946175
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.
Bender D; Hildt E
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546975
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
5. Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma.
Xu L; Xu Y; Zhang F; Xu P; Wang L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):64-72. PubMed ID: 38426692
[TBL] [Abstract][Full Text] [Related]
6. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma.
D'souza S; Lau KC; Coffin CS; Patel TR
World J Gastroenterol; 2020 Oct; 26(38):5759-5783. PubMed ID: 33132633
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
9. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.
Dakurah OB; Tamandjou CRT; Zunza M; Preiser W; Maponga TG
BMC Cancer; 2021 Jun; 21(1):715. PubMed ID: 34144696
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].
Glitscher M; Hildt E; Bender D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):228-237. PubMed ID: 35015106
[TBL] [Abstract][Full Text] [Related]
12. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
Miyakawa H; Izumi N; Marumo F; Sato C
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
[TBL] [Abstract][Full Text] [Related]
13. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
14. Genotypic variability of hepatitis viruses associated with chronic infection and the development of hepatocellular carcinoma.
Pujol FH; Devesa M
J Clin Gastroenterol; 2005 Aug; 39(7):611-8. PubMed ID: 16000930
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence.
Mohamed EA; Giama NH; Abdalla AO; Shaleh HM; Oseini AM; Ali HA; Ahmed F; Taha W; Ahmed Mohammed H; Cvinar J; Waaeys IA; Ali H; Allotey LK; Ali AO; Mohamed SA; Harmsen WS; Ahmmad EM; Bajwa NA; Afgarshe MD; Shire AM; Balls-Berry JE; Roberts LR
World J Gastroenterol; 2022 Sep; 28(35):5217-5229. PubMed ID: 36188718
[TBL] [Abstract][Full Text] [Related]
16. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management.
Khera L; Paul C; Kaul R
Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
19. Chaperone-Mediated Autophagy in the Liver: Good or Bad?
Dash S; Aydin Y; Moroz K
Cells; 2019 Oct; 8(11):. PubMed ID: 31652893
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
